These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22730854)

  • 21. The Spanish Society of Pulmonology and Thoracic Surgery Lung Cancer Cooperative Group-II registry. A descriptive study.
    Sánchez de Cos Escuín J; Serra Mitjans M; Hernández Hernández J; Hernández Rodríguez H; Abal Arca J; Parente Lamelas I; León Atance P; Núñez Ares A; Miravet Sorribes L; Blanco Orozco AI; Melchor ĺñiguez R; García Arangüena L; Arnau Obrer A; Guijarro Jorge R; Padilla Alarcón J; Peñalver Cuesta JC; Mariñán Gorospe M; Fernández Araujo E; Francisco Corral G; Cerezo González S; González Casaurrán G; Naranjo Gozalo S; Álvarez de Arriba C; Núñez Delgado M; González Budiño MT; Magaroles R; de Esteban Júlvez L; Pavón Fernández MJ; Gullón Blanco JA; de Olaiz Navarro B; Escobar Campuzano I; Macía Vidueira I; García Barajas S; Herrero Collantes J; Freixenet Gilabert J; Saura Vinuesa A
    Arch Bronconeumol; 2013 Nov; 49(11):462-7. PubMed ID: 23838409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. False-positivity of mediastinal lymph nodes has negative effect on survival in potentially resectable non-small cell lung cancer.
    Iskender I; Kadioglu SZ; Cosgun T; Kapicibasi HO; Sagiroglu G; Kosar A; Kir A
    Eur J Cardiothorac Surg; 2012 Apr; 41(4):874-9. PubMed ID: 22423060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer: comparisons of clinical effectiveness in a randomized trial.
    Yi CA; Lee KS; Lee HY; Kim S; Kwon OJ; Kim H; Choi JY; Kim BT; Hwang HS; Shim YM
    Cancer; 2013 May; 119(10):1784-91. PubMed ID: 23423920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of flexible bronchoscopy for the preoperative assessment of NSCLC diagnosed using percutaneous core needle biopsy.
    Jo KW; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Choi CM
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):593-8. PubMed ID: 25025892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of preoperative 18F-FDG PET/CT on survival of resected mono-metastatic non-small cell lung cancer.
    Tönnies S; Tönnies M; Kollmeier J; Bauer TT; Förster GJ; Kaiser D; Wernecke KD; Pfannschmidt J
    Lung Cancer; 2016 Mar; 93():28-34. PubMed ID: 26898611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
    Vu CC; Matthews R; Kim B; Franceschi D; Bilfinger TV; Moore WH
    Nucl Med Commun; 2013 Oct; 34(10):959-63. PubMed ID: 23921784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A follow-up of integrated positron emission tomography/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients.
    Cho S; Lee EB
    J Thorac Cardiovasc Surg; 2010 Jun; 139(6):1447-51. PubMed ID: 20005529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Limited predictive value of dual-time-point F-18 FDG PET/CT for evaluation of pathologic N1 status in NSCLC patients.
    Kim SJ; Kim YK; Kim IJ; Kim YD; Lee MK
    Clin Nucl Med; 2011 Jun; 36(6):434-9. PubMed ID: 21552019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Accuracy of Mediastinal Lymph Node Staging Techniques in the Preoperative Assessment of Nonsmall Cell Lung Cancer Patients.
    Fréchet B; Kazakov J; Thiffault V; Ferraro P; Liberman M
    J Bronchology Interv Pulmonol; 2018 Jan; 25(1):17-24. PubMed ID: 29261576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography with CT in the evaluation of non-small cell lung cancer in populations with a high prevalence of tuberculosis.
    Low SY; Eng P; Keng GH; Ng DC
    Respirology; 2006 Jan; 11(1):84-9. PubMed ID: 16423207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-tumour 18F-FDG uptake heterogeneity decreases the reliability on target volume definition with positron emission tomography/computed tomography imaging.
    Dong X; Wu P; Sun X; Li W; Wan H; Yu J; Xing L
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):338-45. PubMed ID: 25708154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N; Sawabata N; Minami M; Inoue M; Shintani Y; Kadota Y; Okumura M
    Eur J Cardiothorac Surg; 2012 Jul; 42(1):89-92. PubMed ID: 22290887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
    Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
    Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it safe to include octogenarians at the start of a video-assisted thoracic surgery lobectomy programme?
    Amer K; Khan AZ; Vohra H; Saad R
    Eur J Cardiothorac Surg; 2012 Feb; 41(2):346-52. PubMed ID: 21900023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Guidelines for the role of FDG-PET/CT in lung cancer management.
    Al-Jahdali H; Khan AN; Loutfi S; Al-Harbi AS
    J Infect Public Health; 2012 Dec; 5 Suppl 1():S35-40. PubMed ID: 23244185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative staging of lung cancer with combined PET-CT.
    Fischer B; Lassen U; Mortensen J; Larsen S; Loft A; Bertelsen A; Ravn J; Clementsen P; Høgholm A; Larsen K; Rasmussen T; Keiding S; Dirksen A; Gerke O; Skov B; Steffensen I; Hansen H; Vilmann P; Jacobsen G; Backer V; Maltbaek N; Pedersen J; Madsen H; Nielsen H; Højgaard L
    N Engl J Med; 2009 Jul; 361(1):32-9. PubMed ID: 19571281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Impact of positron emission tomography on clinical management of potentially resectable non-small-cell lung cancer: a French prospective multicenter study].
    Margery J; Milleron B; Vaylet F; Grahek D; Lebeau B; Mangiapan G; Bonardel G; de Labriolle-Vaylet C; Meignan M; Carette MF; Talbot JN; Housset B
    Rev Pneumol Clin; 2010 Oct; 66(5):313-20. PubMed ID: 21087727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Waiting times in early-stage non-small cell lung cancer (NSCLC).
    Saint-Jacques N; Rayson D; Al-Fayea T; Virik K; Morzycki W; Younis T
    J Thorac Oncol; 2008 Aug; 3(8):865-70. PubMed ID: 18670304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer.
    Watanabe S; Asamura H; Suzuki K; Tsuchiya R
    Ann Thorac Surg; 2005 May; 79(5):1682-5. PubMed ID: 15854954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.